CD79A and COVID-19: The absence of anti-SARS-CoV-2 serum IgA and secretory IgA may explain the severity of COVID-19, vaccine ineffectiveness, and prolonged viral shedding in patients with primary antibody deficiencies, including selective IgA deficiency [56].